We are the leading funder of brain tumour research in the UK, committing over £35.6 million to date on pioneering projects that will help adults and children with brain tumours.
We spend 80p in every £1 donated on our charitable aims, so the more we raise, the more we will invest in research. We fund research through a competitive, fair and transparent process of best practice called peer review to ensure we only select the very best research that will have a real impact on those affected by brain tumours.
Learn more about our groundbreaking £5 million investment for research into Paediatric Low Grade Brain Tumours.
PNET5 aims to prove that children diagnosed with a lower risk medulloblastoma would benefit from less aggressive treatment
These programmes bring together global teams from different disciplines to target the research from different approaches.
To enhance life today these projects aim to have a direct benefit on the everyday lives of people affected by a brain tumour.
These projects are testing ideas that haven't been tried in brain tumours previously, to make new discoveries for the field.
This research acknowledges the importance of international and interdisciplinary team approaches to accelerate research.
This scheme has been established to focus research onto reducing the burden and harm to those diagnosed with a brain tumour.
This research involves innovative approaches that could change our understanding, diagnosis and management of brain tumours.
We're partnering with the Structural Genomics Consoritum, funding two researchers who will be searching for new drugs.